Found: 95
Select item for more details and to access through your institution.
From a PMT-based to a SiPM-based PET system: a study to define matched acquisition/reconstruction parameters and NEMA performance of the Biograph Vision 450.
- Published in:
- EJNMMI Physics, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40658-020-00323-w
- By:
- Publication type:
- Article
Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study).
- Published in:
- AUANews, 2023, p. 8
- By:
- Publication type:
- Article
Comparative Toxicity and Efficacy of Combined Radioimmunotherapy and Antiangiogenic Therapy in Carcinoembryonic Antigen-Expressing Medullary Thyroid Cancer Xenograft.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 4, p. 624, doi. 10.2967/jnumed.109.070714
- By:
- Publication type:
- Article
Does <sup>18</sup>F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 1, p. 24, doi. 10.2967/jnumed.108.055806
- By:
- Publication type:
- Article
Targeting, Toxicity, and Efficacy of 2-Step, Pretargeted Radioimmunotherapy Using a Chimeric Bispecific Antibody and <sup>131</sup>I-Labeled Bivalent Hapten in a Phase I Optimization Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 2, p. 247
- By:
- Publication type:
- Article
Radioimmunotherapy of Non-Hodgkin's Lymphoma with <sup>90</sup>Y-DOTA Humanized Anti-CD22 IgG (<sup>90</sup>Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 12, p. 2000
- By:
- Publication type:
- Article
Two-Step Targeting and Dosimetry for Small Cell Lung Cancer Xenograft with Anti-NCAM/Antihistamine Bispecific Antibody and Radioiodinated Bivalent Hapten.
- Published in:
- Journal of Nuclear Medicine, 1999, v. 40, n. 7, p. 1216
- By:
- Publication type:
- Article
Bispecific Antibody and Bivalent Hapten Radioimmunotherapy in CEA-Producing Medullary Thyroid Cancer Xenograft.
- Published in:
- Journal of Nuclear Medicine, 1999, v. 40, n. 1, p. 198
- By:
- Publication type:
- Article
Biodistribution and Dosimetric Study in Medullary Thyroid Cancer Xenograft Using Bispecific Antibody and Iodine-125-Labeled Bivalent Hapten.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 9, p. 1608
- By:
- Publication type:
- Article
Semi-Quantitative [ 18 F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15528, doi. 10.3390/ijms232415528
- By:
- Publication type:
- Article
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5406, doi. 10.3390/ijms21155406
- By:
- Publication type:
- Article
What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2564, doi. 10.3390/ijms20102564
- By:
- Publication type:
- Article
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 445, doi. 10.3390/ijms18020445
- By:
- Publication type:
- Article
Immuno-PET for Clinical Theranostic Approaches.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 1, p. 57, doi. 10.3390/ijms18010057
- By:
- Publication type:
- Article
Tumor Immunotargeting Using Innovative Radionuclides.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 2, p. 3932, doi. 10.3390/ijms16023932
- By:
- Publication type:
- Article
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00177
- By:
- Publication type:
- Article
Improvement of radioimmunotherapy using pretargeting.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00159
- By:
- Publication type:
- Article
Radio-immunothérapie alpha.
- Published in:
- Médecine Sciences, 2016, v. 32, n. 4, p. 362, doi. 10.1051/medsci/20163204014
- By:
- Publication type:
- Article
Prognostic Value of <sup>18</sup>F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 156, doi. 10.2967/jnumed.123.265872
- By:
- Publication type:
- Article
Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1706, doi. 10.2967/jnumed.123.265871
- By:
- Publication type:
- Article
New Developments in Myeloma Treatment and Response Assessment.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1331, doi. 10.2967/jnumed.122.264972
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 257, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
<sup>18</sup>F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 9, p. 1380, doi. 10.2967/jnumed.117.206920
- By:
- Publication type:
- Article
Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 4, p. 714, doi. 10.2967/jnumed.117.205351
- By:
- Publication type:
- Article
Radioimmunotherapy: From Current Clinical Success to Future Industrial Breakthrough?
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 3, p. 329, doi. 10.2967/jnumed.115.167247
- By:
- Publication type:
- Article
Laparoscopic Sentinel Lymph Node Versus Hyperextensive Pelvic Dissection for Staging Clinically Localized Prostate Carcinoma: A Prospective Study of 200 Patients.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 5, p. 753, doi. 10.2967/jnumed.113.129023
- By:
- Publication type:
- Article
Differences in the Biologic Activity of 2 Novel MEK Inhibitors Revealed by <sup>18</sup>F-FDG PET: Analysis of Imaging Data from 2 Phase I Trials.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 12, p. 1836, doi. 10.2967/jnumed.112.109421
- By:
- Publication type:
- Article
Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 8, p. 1185, doi. 10.2967/jnumed.111.101865
- By:
- Publication type:
- Article
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 4, p. 947, doi. 10.1007/s00259-023-06568-8
- By:
- Publication type:
- Article
Multiple myeloma mimicking metastatic skull base paraganglioma in [<sup>68</sup> Ga]Ga-DOTATOC-PET/CT and 2-[<sup>18</sup>F]FDG-PET/CT imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 12, p. 3792, doi. 10.1007/s00259-023-06322-0
- By:
- Publication type:
- Article
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutation.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.8
- By:
- Publication type:
- Article
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 12, p. 4590, doi. 10.1210/jc.2007-0938
- By:
- Publication type:
- Article
Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 11, p. 6077, doi. 10.1210/jc.2005-0044
- By:
- Publication type:
- Article
Pretargeting for imaging and therapy in oncological nuclear medicine.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2017, v. 2, n. 1, p. 1, doi. 10.1186/s41181-017-0026-8
- By:
- Publication type:
- Article
Rheumatic involvement and bone scan features in Schnitzler syndrome: initial and follow-up data from a single-center cohort of 25 patients.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. N.PAG, doi. 10.1186/s13075-020-02318-5
- By:
- Publication type:
- Article